Research Spotlight: Innovative Nanovaccine Found to Trigger an Anti-Tumor Response for Rare Cancer
Researchers used a nanovaccine to trigger an anti-tumor response for a rare form of melanoma.
Our main office is conveniently located at 50 Staniford Street in Boston, near public transportation.
The Massachusetts General Hospital Department of Dermatology delivers state-of-the-art care to patients with rare and common conditions of the skin, hair and nails.
Our department's board-certified physicians have one overarching goal: helping patients enjoy their everyday activities while minimizing or eliminating their symptoms. Referring physicians also consult us to clarify challenging diagnoses.
We provide the most advanced treatments for conditions including:
Additionally, our world-class medical staff treats acute and rare diseases and disorders, such as:
Since the 1800s, we have led the way in developing new treatments for skin conditions, including:
We also opened the first multidisciplinary center for patients with cutaneous melanoma in 1966.
In the 21st century, we continue to break new ground. The Clinical Unit for Research Trials in Skin helps patients who have not responded to traditional treatments and develops novel therapies, diagnostics, clinical procedures and medications. Our Cutaneous Biology Research Center works on discovering fundamental principles and genetics that contribute to maintaining healthy skin and treating disease.
With more than 90,000 visits annually, we are trusted by patients throughout New England. In addition to our general dermatology clinics we offer the following specialty services:
Specialty treatment programs are offered at our Boston location at 50 Staniford Street. Additionally, we also general and medical dermatology services at Mass General North in Danvers and at Mass General Health Centers in Charlestown, Revere, and Chelsea.
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
Researchers used a nanovaccine to trigger an anti-tumor response for a rare form of melanoma.
Shadmehr (Shawn) Demehri, MD, PhD, is the corresponding author of a paper published in Cancer Cell, “Commensal papillomavirus immunity preserves the homeostasis of highly mutated normal skin.”
The paper describes a first-of-its-kind spatial multiomic atlas derived from nearly one million cells of the first trimester human placenta at single-cell and molecular resolution.
Shawn Demehri, MD, PhD, director of the Massachusetts General Hospital High Risk Skin Cancer Clinic, discusses the risk factors for basal cell carcinoma, the signs of skin cancer, and prevention tips that can help you protect your skin all year round.
Study results indicate that pitavastatin inhibits an inflammatory pathway that in turn can suppress skin and pancreatic cancers.
What started as an investigation into a rare skin disease led one researcher to new insights about kidney formation and function.
The best times to call for appointments are Monday- Friday from 9:00am-12 noon and 1:00pm to 5:00pm. Our main office can schedule appointments for both the Boston and the Danvers locations.